NanoViricides
NNVC
#10253
Rank
S$28 M
Marketcap
S$1.30
Share price
8.57%
Change (1 day)
-7.39%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of September 2025 : S$10.73 Million

According to NanoViricides's latest financial reports the company's total assets are S$10.73 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2025-06-30S$11.21 M-35.45%
2024-06-30S$17.37 M-23.98%
2023-06-30S$22.85 M-30.04%
2022-06-30S$32.66 M-19.74%
2021-06-30S$40.69 M22.1%
2020-06-30S$33.32 M83.33%
2019-06-30S$18.17 M-28.08%
2018-06-30S$25.27 M-32%
2017-06-30S$37.17 M-24.68%
2016-06-30S$49.35 M-17.11%
2015-06-30S$59.53 M8.88%
2014-06-30S$54.68 M162.62%
2013-06-30S$20.82 M5.13%
2012-06-30S$19.8 M50.01%
2011-06-30S$13.2 M5.73%
2010-06-30S$12.48 M188.02%
2009-06-30S$4.33 M116.97%
2008-06-30S$1.99 M-3.52%
2007-06-30S$2.07 M-52.33%
2006-06-30S$4.34 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
S$75.79 B 706,163.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$175.75 B 1,637,625.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$115.61 B 1,077,285.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$105.69 B 984,799.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S$1.51 B 13,978.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.66 B 6,052.36%๐Ÿ‡บ๐Ÿ‡ธ USA